✦ LIBER ✦

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial

✍ Scribed by John J. Treanor; Hana El Sahly; James King; Irene Graham; Ruvim Izikson; Robert Kohberger; Peter Patriarca; Manon Cox

Book ID: 116964143
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 359 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.07.128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a recombinant hep

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

✍ Feng-Cai Zhu; Jun Zhang; Xue-Feng Zhang; Cheng Zhou; Zhong-Ze Wang; Shou-Jie Hua 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 272 KB

Safety and Immunogenicity of a Recombina

Safety and Immunogenicity of a Recombinant Borrelia burgdorferi Outer Surface Protein A Vaccine Against Lyme Disease in Healthy Children and Adolescents: A Randomized Controlled Trial

✍ Sikand, V. K.; Halsey, N.; Krause, P. J.; Sood, S. K.; Geller, R.; Van Hoecke, C 📂 Article 📅 2001 🏛 American Academy of Pediatrics 🌐 English ⚖ 352 KB